Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

4

About Jeff Rusinow

Jeff Rusinow Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Jeff Rusinow News

Healthtech startup Medicardia closes $3m post seed round to accelerate growth

Oct 22, 2021

Medicardia Health announced it has raised $3 million in its first major financing round. Founded in 2020, the company was initially bootstrapped by CEO and Founder Indrajit Choudhuri and associates, and was provided seed capital by angel investor Jeff Rusinow. Read More >>

Jeff Rusinow Investments

4 Investments

Jeff Rusinow has made 4 investments. Their latest investment was in Men's Style Lab as part of their Angel on December 12, 2014.

CBI Logo

Jeff Rusinow Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/2/2014

Angel

Men's Style Lab

$1.1M

Yes

Rick Leto, and Undisclosed Investors

2

6/2/2014

Angel

Subscribe to see more

$99M

Subscribe to see more

10

1/3/2011

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Angel

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/2/2014

6/2/2014

1/3/2011

Round

Angel

Angel

Seed VC

Angel

Company

Men's Style Lab

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$1.1M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Rick Leto, and Undisclosed Investors

Sources

2

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.